The biological and prognostic significance of KLRG1-defined CD8 T cell subsets in follicular lymphoma (FL) has been determined, which implies that managing CD8 + T-cell differentiation in FL may improve the clinical prognosis of lymphoma patients by enhancing the antitumour immune response [24]. The gene discussed is CD8A; the disease is follicular lymphoma.